| Betterchem |
|
|
| FDA approval activities
for this prescription drug:
Arimidex (anastrozole) Tablets, AstraZeneca NDA 20-541/S10 9/5/02 9/11/02 9/5/02 7/8/03 Arimidex (anastrozole) Tablets, AstraZeneca NDA 20-541/S-005, S-009 10/7/02 10/11/01 Arimidex (anastrozole) Tablets, AstraZeneca NDA 20-541/S-006 9/1/00 9/21/00 7/12/01 7/12/01 Arimidex Indication: for the first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. |
© 2007 Betterchem Corp.
|